Protego Biopharma Revenue and Competitors
Estimated Revenue & Valuation
- Protego Biopharma's estimated annual revenue is currently $2.6M per year.
- Protego Biopharma's estimated revenue per employee is $77,500
- Protego Biopharma's total funding is $51M.
Employee Data
- Protego Biopharma has 34 Employees.
- Protego Biopharma grew their employee count by 31% last year.
Protego Biopharma's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-founder, VP Biology | Reveal Email/Phone |
2 | VP, Finance & Administration | Reveal Email/Phone |
3 | VP Chemistry | Reveal Email/Phone |
4 | Director Program Management | Reveal Email/Phone |
5 | Chief Business Officer | Reveal Email/Phone |
6 | Assistant Controller | Reveal Email/Phone |
7 | Principle Scientist II | Reveal Email/Phone |
8 | Associate Research Scientist | Reveal Email/Phone |
9 | Associate Research Scientist | Reveal Email/Phone |
10 | Principal Scientist | Reveal Email/Phone |
Protego Biopharma Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Protego Biopharma?
Protego Biopharma focuses on developing therapeutics and companion diagnostics targeting protein misfolding diseases.
keywords:N/A
$51M
Total Funding
34
Number of Employees
$2.6M
Revenue (est)
31%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Protego Biopharma News
2022-04-19 - Cassava Sciences Hits Back at NYT For Alleged "Pre-Set ...
He noted that one of the critics cited was behind the $51 million Series A financing for Protego Biopharma, which is focused on developing...
2022-04-17 - Cassava Sciences responds to simufilam study allegations in The New York
Times
Cassava wrote that Bredt's former employer, MPM Venture Capital, co-led a $51 million investment in a startup Protego Biopharma that focuses...
Other Companies in San Diego
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $9.5M | 34 | 6% | N/A |
#2 | $5.7M | 34 | -8% | N/A |
#3 | $3.9M | 34 | N/A | N/A |
#4 | $2.6M | 34 | 31% | $43M |
#5 | $3.6M | 34 | -41% | $132.5M |